Therapeutic Asset Ratings

186 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Fenofibrate Peripheral Neuropathy	Tanta University	P4	B (62)
Obeticholic Acid Nonalcoholic Steatohepatitis	Tanta University	P3	B (62)
L-Bupivacaine Chronic Pain	Tanta University	P4	B (61)
Roflumilast Depressive Disorder, Major	Tanta University	P3	B (61)
Baclofen Laparoscopic Sleeve Gastrectomy	Tanta University	P2/3	B (61)
10-(1-methylpiperidin-4-ylidene)-5,10-dihydro-4H-benzo[5,6]cyclohepta[1,2-b]thiophen-4-one Neuropathy;Peripheral	Tanta University	P3	B (60)
Capecitabine Hand and Foot Syndrome	Tanta University	P3	B (60)
Capecitabine HFS	Tanta University	P3	B (60)
DL-6,8-THIOCTIC ACID Beta Thalassemia	Tanta University	P3	B (60)
D-thioctic acid Beta Thalassemia	Tanta University	P3	B (60)
Empagliflozin Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics	Tanta University	P3	B (60)
L-Carnitine Beta Thalassemia With Increased Tricuspid Regurgitant Jet Velocity	Tanta University	P3	B (60)
Metformin Epilepsy	Tanta University	P3	B (60)
N-Acetyl-L-Cysteine Beta Thalassemia	Tanta University	P3	B (60)
Olanzapine Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics	Tanta University	P3	B (60)
PROPRANOLOL Intracranial Pressure	Tanta University	P3	B (60)
VARINON Non Alcoholic Steatohepatitis	Tanta University	P3	B (60)
PHYTONADIONE, (E)-(±)- Cirrhosis	Tanta University	P4	B (59)
Zolmitriptanee Migraine	Tanta University	P4	B (59)
coq10 Nonalcoholic Steatohepatitis	Tanta University	P3	B (59)
Allopurinol Cirrhosis	Tanta University	P2/3	B (59)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Obesity	Tanta University	P4	B (58)
Dfn-15 HFS	Tanta University	P3	B (58)
Letrozole Parkinson Disease	Tanta University	P3	B (58)
Metformin Parkinson Disease	Tanta University	P3	B (58)

Showing 51 to 75 of 186 assets

PreviousPage 3 of 8Next